Press Releases

TORRANCE, Calif., Sept. 10, 2019 /PRNewswire/ -- Emmaus Life Sciences, Inc. (Nasdaq: EMMA), a leader in sickle cell disease treatment, announced today that it was informed yesterday that the Nasdaq Hearings Panel had declined to reverse the Nasdaq Listing Qualification's decision to delist Emmaus common stock and warrants. As a result, E

NEW YORK, Sept. 10, 2019 /PRNewswire/ -- Today, Senior Helpers®, the nation's premier provider of in-home senior care, announced that it has begun deploying the indust

LAKE FOREST, Calif., Sept. 10, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq:INMD) ("InMode"), a leading global provider of innovative medical technologies, hosted over 600 physicians and medical professionals at its Inaugural North American User Meeting, titled the "Insider Summit," in August 2019 in Nashville, Te

HOUSTON, Sept. 10, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that it has selected Clear Dermatology & Aesthe

DULUTH, Ga., Sept. 10, 2019 /PRNewswire/ -- Lyme disease in dogs is caused by one of the fastest-growing tick-transmitted bacterial infections in the United States – and it can cause major health problems in dogs.

BIRMINGHAM, Ala., Sept. 10, 2019 /PRNewswire/ -- Yuva Biosciences, Inc., an anti-aging company developing cosmeceuticals as well as pharmaceuticals targeted at aging-associated hair loss, wrinkled skin, and reduced energy, today announced that Aubrey de Grey, Ph.D. and Frank L. Jaksch, Jr. have joined

Second Annual Report Reinforces the Company's Continued Commitment to Responsible, Ethical and Sustainable Operations LAVAL, Quebec, Sept. 10, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today released its second annual

BOISE, Idaho, Sept. 10, 2019 /PRNewswire/ -- As part of its commitment to prevent opioid misuse, Albertsons Companies now offers

Company announces record Q3 2019 revenue guidance of $16 million – $17 million  KELOWNA, Sept. 10, 2019 /PRNewswire/ - Valens GroWorks Corp. (TSXV: VGW) (OTCQX: VGWCF) (the "Company" or "Valens"), a vertically integrated provider of indus

SUNNYVALE, Calif., Sept. 10, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Geisinger Medical Center radiation oncology team is first in Pennsylvania to treat cancer patients with the innovative